RecruitingPhase 4NCT07221877
A Study to Evaluate the Effect of KarXT on Urological Safety
Sponsor: Bristol-Myers Squibb
Chicago, IL · +14 more sites
Schizophrenia clinical trials in Chicago, IL
23 recruiting schizophrenia studies with a site in Chicago, IL.
RecruitingPhase 3NCT07424404
A Study to Evaluate the Long-term Safety and Tolerability of Xanomeline and Trospium Chloride for the Treatment of Psychiatric Disorders in Children and Adolescents
Sponsor: Karuna Therapeutics, Inc., a Bristol Myers Squibb company
Chicago, IL · +54 more sites
RecruitingPhase 2NCT07459647
A Long-Term Open-Label Study of ML-007C-MA in Adults With Schizophrenia
Sponsor: MapLight Therapeutics
Chicago, IL · +44 more sites
RecruitingPhase 2NCT07410507
A Study of Brenipatide in Adult Participants With Schizophrenia
Sponsor: Eli Lilly and Company
Chicago, IL · +31 more sites
RecruitingPhase 3NCT07288567
A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Schizophrenia in Adolescents (EMERGENT TEEN)
Sponsor: Bristol-Myers Squibb
Chicago, IL · +18 more sites
RecruitingNot applicableNCT07853807
Cognitive Neurocomputational Task Reliability & Clinical Applications Consortium (CNTRACS): Study 1
Sponsor: Washington University School of Medicine
Chicago, IL · +4 more sites
RecruitingPhase 1NCT07615426
A Study of the Feasibility, Safety and Tolerability of Aticaprant as Adjunctive Treatment in Participants With Schizophrenia
Sponsor: Janssen Research & Development, LLC
Chicago, IL · +7 more sites
RecruitingPhase 3NCT07686263
Relapse Prevention Trial Evaluating KarXT Treatment in Schizophrenia
Sponsor: Karuna Therapeutics, Inc., a Bristol Myers Squibb company
Chicago, IL · +32 more sites
RecruitingPhase 3NCT07114874
NBI-1117568-SCZ3032: Long-Term Evaluation of NBI-1117568 in Adults With Schizophrenia
Sponsor: Neurocrine Biosciences
Chicago, IL · Oak Brook, IL · +48 more sites
RecruitingPhase 3NCT07369154
52-week Open Label Safety-Tolerability Study
Sponsor: LB Pharmaceuticals Inc.
Chicago, IL · +22 more sites
RecruitingPhase 1NCT07061288
A Study to Evaluate the Safety, Tolerability, and PK of an Injectable Form of KarXT
Sponsor: Bristol-Myers Squibb
Chicago, IL · +7 more sites
RecruitingPhase 3NCT05303064
Study to Evaluate Weight Gain as Assessed by Change in BMI Z-score in Pediatric Subjects With Schizophrenia or Bipolar I Disorder
Sponsor: Alkermes, Inc.
Chicago, IL · +25 more sites
RecruitingPhase 2NCT07467993
Study to Assess the Safety, Tolerability, and Treatment Response of GXV813 in Hospitalized Adults With Schizophrenia
Sponsor: Novartis Pharmaceuticals
Chicago, IL · +5 more sites
RecruitingPhase 3NCT07363577
Study to Evaluate LB-102 for the Treatment of Adult Patients With Acute Schizophrenia
Sponsor: LB Pharmaceuticals Inc.
Chicago, IL · +12 more sites
RecruitingPhase not listedNCT07713849
Transition Care for FEP
Sponsor: University of Chicago
Chicago, IL · Harvey, IL
RecruitingPhase 2NCT07191483
A Study to Evaluate KYN-5356 in Adults With Cognitive Impairment Associated With Schizophrenia
Sponsor: Kynexis B.V.
Chicago, IL · +14 more sites
RecruitingPhase 4NCT04580134
CLOZAPINE Response in Biotype-1
Sponsor: University of Texas Southwestern Medical Center
Chicago, IL · +4 more sites
RecruitingPhase not listedNCT06740383
Biomarkers/Biotypes, Course of Early Psychosis and Specialty Services
Sponsor: Beth Israel Deaconess Medical Center
Chicago, IL · +5 more sites
RecruitingPhase 3NCT06963034
NBI-1117568-SCZ3029: Evaluation of NBI-1117568 in Inpatient Adults With Schizophrenia
Sponsor: Neurocrine Biosciences
Chicago, IL · +20 more sites
RecruitingPhase 3NCT06961968
Randomized Withdrawal Study in Patients With Schizophrenia
Sponsor: Vanda Pharmaceuticals
Chicago, IL · +21 more sites
RecruitingPhase 2NCT06502964
Study of ALTO-101 in Patients With Schizophrenia
Sponsor: Alto Neuroscience
Chicago, IL · +13 more sites
RecruitingPhase 3NCT05184335
Safety and Efficacy of Brilaroxazine (RP5063) in Schizophrenia
Sponsor: Reviva Pharmaceuticals
Chicago, IL · +17 more sites
Not yet recruitingNot applicableNCT07875790
Cognitive Neurocomputational Task Reliability and Clinical Applications Consortium: Study 2
Sponsor: Washington University School of Medicine
Chicago, IL · +4 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.